These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 24435775

  • 1. Diagnostic accuracy of ¹⁸F-FDG PET/CT for detection of suspected recurrence in patients with oesophageal carcinoma.
    Sharma P, Jain S, Karunanithi S, Pal S, Julka PK, Thulkar S, Malhotra A, Bal C, Kumar R.
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1084-92. PubMed ID: 24435775
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diagnostic accuracy of integrated (18)F-FDG PET/CT for restaging patients with malignant germ cell tumours.
    Sharma P, Jain TK, Parida GK, Karunanithi S, Patel C, Sharma A, Thulkar S, Julka PK, Bal C, Kumar R.
    Br J Radiol; 2014 Aug; 87(1040):20140263. PubMed ID: 24896199
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience.
    Sharma P, Jain TK, Singh H, Suman SK, Faizi NA, Kumar R, Bal C, Malhotra A, Kumar R.
    Nucl Med Commun; 2013 Mar; 34(3):211-9. PubMed ID: 23353886
    [Abstract] [Full Text] [Related]

  • 6. 18FDG-PET/CT is useful in the follow-up of surgically treated patients with oesophageal adenocarcinoma.
    Betancourt Cuellar SL, Palacio DP, Wu CC, Carter BW, Correa AM, Hofstetter WL, Marom EM.
    Br J Radiol; 2018 Feb; 91(1082):20170341. PubMed ID: 29125331
    [Abstract] [Full Text] [Related]

  • 7. Use of positron emission tomography in surgery follow-up of esophageal cancer.
    Teyton P, Metges JP, Atmani A, Jestin-Le Tallec V, Volant A, Visvikis D, Bail JP, Pradier O, Lozac'h P, Cheze Le Rest C.
    J Gastrointest Surg; 2009 Mar; 13(3):451-8. PubMed ID: 19023632
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma.
    Kato H, Miyazaki T, Nakajima M, Fukuchi M, Manda R, Kuwano H.
    Br J Surg; 2004 Aug; 91(8):1004-9. PubMed ID: 15286962
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy.
    Hildebrandt MG, Gerke O, Baun C, Falch K, Hansen JA, Farahani ZA, Petersen H, Larsen LB, Duvnjak S, Buskevica I, Bektas S, Søe K, Jylling AM, Ewertz M, Alavi A, Høilund-Carlsen PF.
    J Clin Oncol; 2016 Jun 01; 34(16):1889-97. PubMed ID: 27001573
    [Abstract] [Full Text] [Related]

  • 12. Detection of neck recurrence in patients with differentiated thyroid cancer: comparison of ultrasound, contrast-enhanced CT and (18)F-FDG PET/CT using surgical pathology as a reference standard: (ultrasound vs. CT vs. (18)F-FDG PET/CT in recurrent thyroid cancer).
    Seo YL, Yoon DY, Baek S, Ku YJ, Rho YS, Chung EJ, Koh SH.
    Eur Radiol; 2012 Oct 01; 22(10):2246-54. PubMed ID: 22562091
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis.
    Goense L, van Rossum PS, Reitsma JB, Lam MG, Meijer GJ, van Vulpen M, Ruurda JP, van Hillegersberg R.
    J Nucl Med; 2015 Jul 01; 56(7):995-1002. PubMed ID: 25952733
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
    Yi JS, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY, Roh JL.
    J Surg Oncol; 2012 Nov 01; 106(6):708-12. PubMed ID: 22674652
    [Abstract] [Full Text] [Related]

  • 16. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun 01; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 17. The value of (18) F-FDG-PET/CT imaging in oral cavity cancer patients following surgical reconstruction.
    Müller J, Hüllner M, Strobel K, Huber GF, Burger IA, Haerle SK.
    Laryngoscope; 2015 Aug 01; 125(8):1861-8. PubMed ID: 25892275
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
    Lee YJ, Kim YM, Jung PS, Lee JJ, Kim JK, Kim YT, Nam JH.
    J Gynecol Oncol; 2018 May 01; 29(3):e36. PubMed ID: 29400023
    [Abstract] [Full Text] [Related]

  • 19. Can (18)F-FDG PET/CT scan change treatment planning and be prognostic in recurrent colorectal carcinoma? A prospective and follow-up study.
    Artiko V, Odalovic S, Sobic-Saranovic D, Petrovic M, Stojiljkovic M, Petrovic N, Kozarevic N, Grozdic-Milojevic I, Obradovic V.
    Hell J Nucl Med; 2015 May 01; 18(1):35-41. PubMed ID: 25840571
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.